About Cardiff Oncology Inc - Company Information, Overview, History and Profile
What does Cardiff Oncology Inc do?
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
Cardiff Oncology Inc Management structure
All Gross Remunerations are in USD
Mr. James E. Levine
Chief Financial Officer and Principal Accounting Officer